Skip to search formSkip to main contentSkip to account menu

1-phthalidyl-5-fluorouracil

National Institutes of Health

Related topics

Related topics

3 relations

Narrower (1)

590-S

Broader (1)

Fluorouracil
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1987
1987
[Phase II study of 590-S (1-phthalidyl-5-fluorouracil) in patients with gastrointestinal cancer. Tokyo Cancer Chemotherapy Cooperative Group].
590-S is a new masked compound of 5-fluorouracil, the antimetabolic antitumor agent of the fluorinated pyrimidine group. The safe… 
1987
1987
[A phase II study of 590-S (1-phthalidyl-5-fluorouracil) in patients with breast cancer--multi-center cooperative study--Cooperative Study Group of 590-S in Breast Cancer].
A phase II clinical study involving 16 institutions was performed for the treatment of breast cancer with 590-S, a new masked… 
1986
1986
[Pharmacokinetics of 1-phthalidyl-5-fluorouracil (PH-FU)].
The blood level of PH-FU following oral administration to rabbits and tumor-bearing mice was considerably lower than that of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)